Table 3 Studies reporting hip reconstruction using a custom-made prosthesis or a prothesis with a dual mobility bearing

Current study

3D Custom-made (with dual mobility bearing)

11

30 (10–50) months

21.4

1 of 11

Infection (1 of 11)

Wu [4]

3D Custom-made

28

32.2 (3–75) months

23

3 of 28

Superficial infection (6 of 28)

Peng [27]

3D Custom-made

5

30.3 (18–42) months

19.8

0 of 5

0 of 5

Wang [28]

3D Custom-made

13

27 (24–31) months

23

0 of 13

Delayed wound healing (2 of 13)

Holzapfel [25]

Custom-made

56

66 (1–270) months

18.4

11 of 56

Infection (14 of 56), delayed wound healing (10 of 56), loosening (3 of 56)

Sun [24]

Custom-made

16

36 (23–62) months

21.6

3 of 16

Delayed wound healing (6 of 16), prosthesis breakage (4 of 16), deep infection (1 of 16)

Guo [23]

Custom-made

18

41 (7–73) months

21.5

2 of 18

Delayed wound healing (2 of 18), deep vein thrombosis (1 of 18), loosening (1 of 18) and sciatic nerve palsy (1 of 18)

Jiaswal [22]

Custom-made

98

65 (2–33.5) months

Mean TESS score 17.8 of 30

19 of 98

Infection (30 of 98), loosening (3 of 98)and deep-vein thrombosis(7 of 98)

Dai [21]

3D Custom-made

10

34 (21–48) months

70% Good function

2 of 10

Deep infection (3 of 10), aseptic loosening (1 of 10)

Ozaki [20]

Custom-made

12

57 (26–77) months

Mean MSTS-87 score 11 of 30

1 of 12

Deep infection (3 of 12), loosening (3 of 12) and recurrence (4 of 12)

Abudu [19]

Custom-made

35

34 (12–312) months

21

6 of 35

Deep infection (9 of 35), aseptic loosening (2 of 35) and thromboembolism (1 of 35)

Bus [18]

Pedestal cup endoprosthesis; 24 with dual mobility cups

47

Minimum 24 months

21

10 of 47 (dual mobility cups, 1 of 24)

Deep infection (13 of 47), loosening (3 of 47)

Philippeau [17]

Dual mobility acetabular cups

71 (33 primary tumor, 38 with metastasis)

Primary, 3.3 years (0.6–7.1; metastasis, 1.25 years (0.2–7.9)

Metastasis, 20.4; Primary, 17.9

7 of 71

Deep infection (7 of 71), loosening (4 of 71)